EvolusAesthetic
Evolus is a performance beauty company focused on delivering breakthrough products.
Get ready to celebrate our favorite day of the year.
This is one event you won’t want to miss.
Stay tuned to learn more.
For full Prescribing Information, including Boxed Warning and Medication Guide, see JEUVEAU | PRODUCT INFORMATION or visit evolusrx.com
Jeuveau® (prabotulinumtoxinA-xvfs) is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients.
The effects of all botulinum toxin products, including Jeuveau, may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. Jeuveau is not approved for the treatment of spasticity or any conditions other than glabellar lines.
Do not use Jeuveau in individuals with known hypersensitivity to any botulinum toxin preparation or to any of the components in the formulation, and in the presence of infection at the proposed injection site.
See full Prescribing Information for complete product information.
Rx Only
For US Healthcare Professionals
US-JUV-2600439
10/19/2026
The modern patient experience is upon us.
Join us for a very special webinar discussing the latest in patient trends and what the demographic is prioritizing now. With science and safety in the forefront of every formula, and the beauty enthusiast at the brink of aesthetic exploration, we discuss how to grow your practice and gain new, loyal patients along the way.
This is where it all begins.
TUNE IN:
Monday, 11/2
7:30PM EST/4:30PM PST
Featuring:
Jason Bloom, MD, FACS
Alexa Costa, NP
Click the link in bio to register.
US-UNB-2600326
Great partnerships are about more than products—they’re about support, trust, and helping providers succeed.
For Fay Jouni, NP and Founder of Fay Jouni, AGPCNP- BC, working with the Evolus team has deepened her appreciation for the people behind Jeuveau®. In this reel, she shares how that support, combined with strong patient satisfaction*, has made Jeuveau a go-to recommendation for fellow aesthetic providers.
Watch to hear why Fay chooses Jeuveau.
Interested in learning more about Jeuveau? Visit the link in bio.
For full Prescribing Information, including Boxed Warning and Medication Guide, see JEUVEAU | PRODUCT INFORMATION or visit evolusrx.com
Jeuveau® (prabotulinumtoxinA-xvfs) is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients.
The effects of all botulinum toxin products, including Jeuveau, may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. Jeuveau is not approved for the treatment of spasticity or any conditions other than glabellar lines.
Do not use Jeuveau in individuals with known hypersensitivity to any botulinum toxin preparation or to any of the components in the formulation, and in the presence of infection at the proposed injection site.
See full Prescribing Information for complete product information.
*Rzany, et al., Aesthetic Surgery Journal 2020, Vol 40(4) 413–429
Rx Only
For US Healthcare Professionals
US-JUV-2600370v2
Trust isn’t built through products alone. It’s built through honesty, education, and consistent results.
For Chicago injector Aeron Sheffield, DNP, AGNP-C, Aesthetic NP | Botox & Filler Expert STL + CHI, patient relationships start with transparency and end with confidence. That’s why he chooses Jeuveau® to deliver predictable, reliable outcomes his patients can trust.
Interested in learning more about Jeuveau? Visit the “Choose Jeuveau” link in bio.
For full Prescribing Information, including Boxed Warning and Medication Guide, see JEUVEAU | PRODUCT INFORMATION or visit evolusrx.com
Jeuveau® (prabotulinumtoxinA-xvfs) is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients.
The effects of all botulinum toxin products, including Jeuveau, may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. Jeuveau is not approved for the treatment of spasticity or any conditions other than glabellar lines.
Do not use Jeuveau in individuals with known hypersensitivity to any botulinum toxin preparation or to any of the components in the formulation, and in the presence of infection at the proposed injection site.
See full Prescribing Information for complete product information.
Rx Only
For US Healthcare Professionals
US-JUV-2600394
Introducing Wings By Evolus.
At Evolus®, love has always been part of who we are,
Our community is at the heart of what we do,
And together, we’re giving back, beyond the treatment room.
For the entire month of October, for every Evolus Rewards™ patient check-in, Wings By Evolus is donating $1 to Look Good Feel Better® (up to $50,000), helping support cancer patients during their time of treatment.
Wings By Evolus reflects how small actions, when taken together, can create meaningful change.
Click the link in bio to get involved.
Terms and Conditions apply. See Evolus Rewards T&Cs.
US-UNB-2600303
When Fay Jouni, NP, first introduced Jeuveau® into her practice, she wanted to see how her patients would respond.
Five years later, the results, and patient enthusiasm, continue to reinforce her decision.
Watch to hear why the founder of Fay Jouni, AGPCNP- BC chooses Jeuveau.
Interested in learning more about Jeuveau? Visit the link in bio.
For full Prescribing Information, including Boxed Warning and Medication Guide, see JEUVEAU | PRODUCT INFORMATION or visit evolusrx.com
Jeuveau® (prabotulinumtoxinA-xvfs) is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients.
The effects of all botulinum toxin products, including Jeuveau, may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. Jeuveau is not approved for the treatment of spasticity or any conditions other than glabellar lines.
Do not use Jeuveau in individuals with known hypersensitivity to any botulinum toxin preparation or to any of the components in the formulation, and in the presence of infection at the proposed injection site.
See full Prescribing Information for complete product information.
Rx Only
For US Healthcare Professionals
US-JUV-2600367v2
Why does Ariel Ostad MD choose Jeuveau®? The precision* and predictability it brings to treating patients’ frown lines. For fellow injectors who value a natural looking result, Jeuveau is worth considering for your tool kit.
Interested in learning more about Jeuveau? Visit the link in bio.
For full Prescribing Information, including Boxed Warning and Medication Guide, see JEUVEAU | PRODUCT INFORMATION or visit evolusrx.com
Jeuveau® (prabotulinumtoxinA-xvfs) is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients.
The effects of all botulinum toxin products, including Jeuveau, may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. Jeuveau is not approved for the treatment of spasticity or any conditions other than glabellar lines.
Do not use Jeuveau in individuals with known hypersensitivity to any botulinum toxin preparation or to any of the components in the formulation, and in the presence of infection at the proposed injection site.
See full Prescribing Information for complete product information.
*Jeuveau PI Date 12.2023
Rx Only
For US Healthcare Professionals
US-JUV-2600404
In aesthetic medicine, precision matters.
For Fay Jouni, NP and Founder of Fay Jouni, AGPCNP- BC, consistency and predictability are key to delivering results patients can trust. That’s why she continues to reach for Jeuveau® — a choice she says helps her achieve precise*, reliable outcomes time and time again.
Watch to hear why Fay chooses Jeuveau®.
(CTA 1): Interested in learning more about Jeuveau? Visit the link in bio.
(CTA 2): DM me for more information on JEUVEAU.
(CTA 3): Interested in learning more about Jeuveau? Visit our YouTube at the link in bio.
For full Prescribing Information, including Boxed Warning and Medication Guide, see JEUVEAU | PRODUCT INFORMATION or visit evolusrx.com
Jeuveau® (prabotulinumtoxinA-xvfs) is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients.
The effects of all botulinum toxin products, including Jeuveau, may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. Jeuveau is not approved for the treatment of spasticity or any conditions other than glabellar lines.
Do not use Jeuveau in individuals with known hypersensitivity to any botulinum toxin preparation or to any of the components in the formulation, and in the presence of infection at the proposed injection site.
See full Prescribing Information for complete product information.
*Jeuveau PI Date 12.2023
Rx Only
For US Healthcare Professionals
US-JUV-2600368
For Ariel Ostad MD, there’s an art to facial assessment — and no room for a cookbook approach. It starts with hearing the patient out and building trust, then mapping out a custom treatment plan.
And when natural-looking results are the goal, his choice for moderate to severe frown lines is Jeuveau® — for the precision and predictability he can count on, treatment after treatment.
DM me for more information on JEUVEAU.
For full Prescribing Information, including Boxed Warning and Medication Guide, see JEUVEAU | PRODUCT INFORMATION or visit evolusrx.com
Jeuveau® (prabotulinumtoxinA-xvfs) is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients.
The effects of all botulinum toxin products, including Jeuveau, may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. Jeuveau is not approved for the treatment of spasticity or any conditions other than glabellar lines.
Do not use Jeuveau in individuals with known hypersensitivity to any botulinum toxin preparation or to any of the components in the formulation, and in the presence of infection at the proposed injection site.
See full Prescribing Information for complete product information.
Rx Only
For US Healthcare Professionals
US-JUV-2600295
Alerts
Be the first to know and let us send you an email when EvolusAesthetic posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Subscribe
We will notify you when anything happens in Newport Beach.